Report cover image

Global Temporal Arteritis Market Research Report 2025(Status and Outlook)

Publisher Bosson Research
Published Mar 24, 2025
Length 170 Pages
SKU # BOSS20076263

Description

Report Overview Temporal arteritis is also known as Horton's arteritis and is considered to be a severe form of vasculitis which means inflammation of the blood vessels. It is a potentially life-threatening inflammatory condition of the arteries. It can cause scalp tenderness and headaches. This condition usually occurs in temporal arteries and may occur in any medium to large artery of the body. As this condition generally occurs in aged population, it is also known as arteritis of the aged. Other names of temporal arteritis includes Horton disease, arteritis cranialis, and granulomatous arteritis. This report provides a deep insight into the global Temporal Arteritis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Temporal Arteritis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Temporal Arteritis market in any manner. Global Temporal Arteritis Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Novartis AG Endo International Inc Teva Pharmaceutical Industries Ltd Glenmark Pharmaceuticals Ltd Cipla Inc Dr Reddy's Laboratories Ltd Abbott F. Hoffmann -La Roche Ltd Pfizer Inc Zydus Group Lupin Amorphex Therapeutics Holdings Inc Bausch Health Companies Inc Regeneron Pharmaceuticals Inc Astellas Pharma Inc Market Segmentation (by Type) Oral Parenteral Market Segmentation (by Application) Hospital Home Care Other Geographic Segmentation • North America (USA, Canada, Mexico) • Europe (Germany, UK, France, Russia, Italy, Rest of Europe) • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) • South America (Brazil, Argentina, Columbia, Rest of South America) • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Key Benefits of This Market Research: • Industry drivers, restraints, and opportunities covered in the study • Neutral perspective on the market performance • Recent industry trends and developments • Competitive landscape & strategies of key players • Potential & niche segments and regions exhibiting promising growth covered • Historical, current, and projected market size, in terms of value • In-depth analysis of the Temporal Arteritis Market • Overview of the regional outlook of the Temporal Arteritis Market: Key Reasons to Buy this Report: • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change • This enables you to anticipate market changes to remain ahead of your competitors • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support Customization of the Report In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met. Chapter Outline Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods. Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Temporal Arteritis Market and its likely evolution in the short to mid-term, and long term. Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market. Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis. Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc. Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years. Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years. Chapter 12 is the main points and conclusions of the report.

Table of Contents

170 Pages
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Temporal Arteritis
1.2 Key Market Segments
1.2.1 Temporal Arteritis Segment by Type
1.2.2 Temporal Arteritis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Temporal Arteritis Market Overview
2.1 Global Market Overview
2.1.1 Global Temporal Arteritis Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Temporal Arteritis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Temporal Arteritis Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Temporal Arteritis Product Life Cycle
3.3 Global Temporal Arteritis Sales by Manufacturers (2020-2025)
3.4 Global Temporal Arteritis Revenue Market Share by Manufacturers (2020-2025)
3.5 Temporal Arteritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Temporal Arteritis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Temporal Arteritis Manufacturing Sites, Area Served, Product Type
3.8 Temporal Arteritis Market Competitive Situation and Trends
3.8.1 Temporal Arteritis Market Concentration Rate
3.8.2 Global 5 and 10 Largest Temporal Arteritis Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Temporal Arteritis Industry Chain Analysis
4.1 Temporal Arteritis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Temporal Arteritis Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Temporal Arteritis Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Temporal Arteritis Market
5.7 ESG Ratings of Leading Companies
6 Temporal Arteritis Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Temporal Arteritis Sales Market Share by Type (2020-2025)
6.3 Global Temporal Arteritis Market Size Market Share by Type (2020-2025)
6.4 Global Temporal Arteritis Price by Type (2020-2025)
7 Temporal Arteritis Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Temporal Arteritis Market Sales by Application (2020-2025)
7.3 Global Temporal Arteritis Market Size (M USD) by Application (2020-2025)
7.4 Global Temporal Arteritis Sales Growth Rate by Application (2020-2025)
8 Temporal Arteritis Market Sales by Region
8.1 Global Temporal Arteritis Sales by Region
8.1.1 Global Temporal Arteritis Sales by Region
8.1.2 Global Temporal Arteritis Sales Market Share by Region
8.2 Global Temporal Arteritis Market Size by Region
8.2.1 Global Temporal Arteritis Market Size by Region
8.2.2 Global Temporal Arteritis Market Size Market Share by Region
8.3 North America
8.3.1 North America Temporal Arteritis Sales by Country
8.3.2 North America Temporal Arteritis Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Temporal Arteritis Sales by Country
8.4.2 Europe Temporal Arteritis Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Temporal Arteritis Sales by Region
8.5.2 Asia Pacific Temporal Arteritis Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Temporal Arteritis Sales by Country
8.6.2 South America Temporal Arteritis Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Temporal Arteritis Sales by Region
8.7.2 Middle East and Africa Temporal Arteritis Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Temporal Arteritis Market Production by Region
9.1 Global Production of Temporal Arteritis by Region(2020-2025)
9.2 Global Temporal Arteritis Revenue Market Share by Region (2020-2025)
9.3 Global Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Temporal Arteritis Production
9.4.1 North America Temporal Arteritis Production Growth Rate (2020-2025)
9.4.2 North America Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Temporal Arteritis Production
9.5.1 Europe Temporal Arteritis Production Growth Rate (2020-2025)
9.5.2 Europe Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Temporal Arteritis Production (2020-2025)
9.6.1 Japan Temporal Arteritis Production Growth Rate (2020-2025)
9.6.2 Japan Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Temporal Arteritis Production (2020-2025)
9.7.1 China Temporal Arteritis Production Growth Rate (2020-2025)
9.7.2 China Temporal Arteritis Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Novartis AG
10.1.1 Novartis AG Basic Information
10.1.2 Novartis AG Temporal Arteritis Product Overview
10.1.3 Novartis AG Temporal Arteritis Product Market Performance
10.1.4 Novartis AG Business Overview
10.1.5 Novartis AG SWOT Analysis
10.1.6 Novartis AG Recent Developments
10.2 Endo International Inc
10.2.1 Endo International Inc Basic Information
10.2.2 Endo International Inc Temporal Arteritis Product Overview
10.2.3 Endo International Inc Temporal Arteritis Product Market Performance
10.2.4 Endo International Inc Business Overview
10.2.5 Endo International Inc SWOT Analysis
10.2.6 Endo International Inc Recent Developments
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Basic Information
10.3.2 Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Overview
10.3.3 Teva Pharmaceutical Industries Ltd Temporal Arteritis Product Market Performance
10.3.4 Teva Pharmaceutical Industries Ltd Business Overview
10.3.5 Teva Pharmaceutical Industries Ltd SWOT Analysis
10.3.6 Teva Pharmaceutical Industries Ltd Recent Developments
10.4 Glenmark Pharmaceuticals Ltd
10.4.1 Glenmark Pharmaceuticals Ltd Basic Information
10.4.2 Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Overview
10.4.3 Glenmark Pharmaceuticals Ltd Temporal Arteritis Product Market Performance
10.4.4 Glenmark Pharmaceuticals Ltd Business Overview
10.4.5 Glenmark Pharmaceuticals Ltd Recent Developments
10.5 Cipla Inc
10.5.1 Cipla Inc Basic Information
10.5.2 Cipla Inc Temporal Arteritis Product Overview
10.5.3 Cipla Inc Temporal Arteritis Product Market Performance
10.5.4 Cipla Inc Business Overview
10.5.5 Cipla Inc Recent Developments
10.6 Dr Reddy's Laboratories Ltd
10.6.1 Dr Reddy's Laboratories Ltd Basic Information
10.6.2 Dr Reddy's Laboratories Ltd Temporal Arteritis Product Overview
10.6.3 Dr Reddy's Laboratories Ltd Temporal Arteritis Product Market Performance
10.6.4 Dr Reddy's Laboratories Ltd Business Overview
10.6.5 Dr Reddy's Laboratories Ltd Recent Developments
10.7 Abbott
10.7.1 Abbott Basic Information
10.7.2 Abbott Temporal Arteritis Product Overview
10.7.3 Abbott Temporal Arteritis Product Market Performance
10.7.4 Abbott Business Overview
10.7.5 Abbott Recent Developments
10.8 F. Hoffmann -La Roche Ltd
10.8.1 F. Hoffmann -La Roche Ltd Basic Information
10.8.2 F. Hoffmann -La Roche Ltd Temporal Arteritis Product Overview
10.8.3 F. Hoffmann -La Roche Ltd Temporal Arteritis Product Market Performance
10.8.4 F. Hoffmann -La Roche Ltd Business Overview
10.8.5 F. Hoffmann -La Roche Ltd Recent Developments
10.9 Pfizer Inc
10.9.1 Pfizer Inc Basic Information
10.9.2 Pfizer Inc Temporal Arteritis Product Overview
10.9.3 Pfizer Inc Temporal Arteritis Product Market Performance
10.9.4 Pfizer Inc Business Overview
10.9.5 Pfizer Inc Recent Developments
10.10 Zydus Group
10.10.1 Zydus Group Basic Information
10.10.2 Zydus Group Temporal Arteritis Product Overview
10.10.3 Zydus Group Temporal Arteritis Product Market Performance
10.10.4 Zydus Group Business Overview
10.10.5 Zydus Group Recent Developments
10.11 Lupin
10.11.1 Lupin Basic Information
10.11.2 Lupin Temporal Arteritis Product Overview
10.11.3 Lupin Temporal Arteritis Product Market Performance
10.11.4 Lupin Business Overview
10.11.5 Lupin Recent Developments
10.12 Amorphex Therapeutics Holdings
10.12.1 Amorphex Therapeutics Holdings Basic Information
10.12.2 Amorphex Therapeutics Holdings Temporal Arteritis Product Overview
10.12.3 Amorphex Therapeutics Holdings Temporal Arteritis Product Market Performance
10.12.4 Amorphex Therapeutics Holdings Business Overview
10.12.5 Amorphex Therapeutics Holdings Recent Developments
10.13 Inc
10.13.1 Inc Basic Information
10.13.2 Inc Temporal Arteritis Product Overview
10.13.3 Inc Temporal Arteritis Product Market Performance
10.13.4 Inc Business Overview
10.13.5 Inc Recent Developments
10.14 Bausch Health Companies Inc
10.14.1 Bausch Health Companies Inc Basic Information
10.14.2 Bausch Health Companies Inc Temporal Arteritis Product Overview
10.14.3 Bausch Health Companies Inc Temporal Arteritis Product Market Performance
10.14.4 Bausch Health Companies Inc Business Overview
10.14.5 Bausch Health Companies Inc Recent Developments
10.15 Regeneron Pharmaceuticals Inc
10.15.1 Regeneron Pharmaceuticals Inc Basic Information
10.15.2 Regeneron Pharmaceuticals Inc Temporal Arteritis Product Overview
10.15.3 Regeneron Pharmaceuticals Inc Temporal Arteritis Product Market Performance
10.15.4 Regeneron Pharmaceuticals Inc Business Overview
10.15.5 Regeneron Pharmaceuticals Inc Recent Developments
10.16 Astellas Pharma Inc
10.16.1 Astellas Pharma Inc Basic Information
10.16.2 Astellas Pharma Inc Temporal Arteritis Product Overview
10.16.3 Astellas Pharma Inc Temporal Arteritis Product Market Performance
10.16.4 Astellas Pharma Inc Business Overview
10.16.5 Astellas Pharma Inc Recent Developments
11 Temporal Arteritis Market Forecast by Region
11.1 Global Temporal Arteritis Market Size Forecast
11.2 Global Temporal Arteritis Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Temporal Arteritis Market Size Forecast by Country
11.2.3 Asia Pacific Temporal Arteritis Market Size Forecast by Region
11.2.4 South America Temporal Arteritis Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Temporal Arteritis by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Temporal Arteritis Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Temporal Arteritis by Type (2026-2033)
12.1.2 Global Temporal Arteritis Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Temporal Arteritis by Type (2026-2033)
12.2 Global Temporal Arteritis Market Forecast by Application (2026-2033)
12.2.1 Global Temporal Arteritis Sales (K Units) Forecast by Application
12.2.2 Global Temporal Arteritis Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.